Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19956
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVan Cutsem, E.en
dc.contributor.authorDicato, M.en
dc.contributor.authorArber, N.en
dc.contributor.authorBerlin, J.en
dc.contributor.authorCervantes, A.en
dc.contributor.authorCiardiello, F.en
dc.contributor.authorDe Gramont, A.en
dc.contributor.authorDiaz-Rubio, E.en
dc.contributor.authorDucreux, M.en
dc.contributor.authorGeva, R.en
dc.contributor.authorGlimelius, B.en
dc.contributor.authorGlynne Jones, R.en
dc.contributor.authorGrothey, A.en
dc.contributor.authorGruenberger, T.en
dc.contributor.authorHaller, D.en
dc.contributor.authorHaustermans, K.en
dc.contributor.authorLabianca, R.en
dc.contributor.authorLenz, H. J.en
dc.contributor.authorMinsky, B.en
dc.contributor.authorNordlinger, B.en
dc.contributor.authorOhtsu, A.en
dc.contributor.authorPavlidis, N.en
dc.contributor.authorRougier, P.en
dc.contributor.authorSchmiegel, W.en
dc.contributor.authorVan de Velde, C.en
dc.contributor.authorSchmoll, H. J.en
dc.contributor.authorSobrero, A.en
dc.contributor.authorTabernero, J.en
dc.date.accessioned2015-11-24T19:04:02Z-
dc.date.available2015-11-24T19:04:02Z-
dc.identifier.issn1569-8041-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/19956-
dc.rightsDefault Licence-
dc.subjectAntineoplastic Agents/adverse effectsen
dc.subjectBiological Markers/metabolismen
dc.subjectCarcinoembryonic Antigen/analysisen
dc.subjectColorectal Neoplasms/*drug therapy/genetics/pathologyen
dc.subjectHumansen
dc.subjectMicrosatellite Instabilityen
dc.subjectMutationen
dc.subjectNeoplasm Metastasisen
dc.subjectPrognosisen
dc.subjectProto-Oncogene Proteins/geneticsen
dc.subjectProto-Oncogene Proteins B-raf/geneticsen
dc.subjectReceptor, Epidermal Growth Factor/antagonists & inhibitorsen
dc.subjectSpainen
dc.subjectras Proteins/geneticsen
dc.titleMolecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009en
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1093/annonc/mdq273-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/20534623-
heal.identifier.secondaryhttp://annonc.oxfordjournals.org/content/21/suppl_6/vi1.full.pdf-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2010-
heal.abstractThe article summarizes the expert discussion and recommendations on the use of molecular markers and of biological targeted therapies in metastatic colorectal cancer (mCRC), as well as a proposed treatment decision strategy for mCRC treatment. The meeting was conducted during the 11th ESMO/World Gastrointestinal Cancer Congress (WGICC) in Barcelona in June 2009. The manuscript describes the outcome of an expert discussion leading to an expert recommendation. The increasing knowledge on clinical and molecular markers and the availability of biological targeted therapies have major implications in the optimal management in mCRC.en
heal.journalNameAnn Oncolen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Van Cutsem-2010-Molecular markers an.pdf145.32 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons